Christian Federau1,2, Maged Goubran3, Jarrett Rosenberg3, Jaimie Henderson4, Casey H Halpern4, Veronica Santini5, Max Wintermark2, Kim Butts Pauly3, Pejman Ghanouni3. 1. University of Basle, Division of Diagnostic and Interventional Neuroradiology, Department of Radiology, Petersgraben, Basle, Switzerland. 2. Stanford University Medical Center, Department of Radiology, Neuroradiology Division, Stanford, California, USA. 3. Stanford University Medical Center, Department of Radiology, Stanford, California, USA. 4. Stanford University Medical Center, Department of Neurosurgery, Stanford, California, USA. 5. Stanford University Medical Center, Department of Neurology, Stanford, California, USA.
Abstract
BACKGROUND: Transcranial MR-guided high-intensity focused ultrasound (tcMRgFUS) is a promising noninvasive method to treat medication-refractory essential tremor. PURPOSE/HYPOTHESIS: To define the correlation between lesion size after ablation, thermal dose, and clinical outcome in tcMRgFUS treatment of essential tremor. STUDY TYPE: Retrospective. POPULATION/SUBJECTS/PHANTOM/SPECIMEN/ANIMAL MODEL: Eight patients with medication-refractory essential tremor were treated using a tcMRgFUS system at 3T. FIELD STRENGTH/SEQUENCE: T2 -weighted images were acquired immediately and at 1 year posttreatment at 3T. ASSESSMENT: An atlas of the thalamic nuclei and dose maps were warped to the posttreatment images. The thermal dose, the immediate posttreatment lesion volume and 1-year final lesion volume, and the volumes confined inside the ventral division of the ventral lateral posterior thalamic nucleus (VLpv) were correlated to clinical outcome at 1 month and 1 year using Pearson's coefficient. The spatial region of treatment correlating with maximal clinical outcome was derived in a normalized space from average maps of clinical tremor score improvement at 1 year. STATISTICAL TESTS: Statistical significance was assessed using the Wilcoxon two-tailed rank test. RESULTS: The correlations between thermal dose, lesion volume posttreatment and at 1 year, and outcome at 1 year were good (r = 0.73, 0.65, 0.73, respectively), and were slightly better than at 1 month (r = 0.57, 0.49, 0.65). Reducing the measurement to include only the portion within the VLpv did not significantly modify the correlations (P = 0.09). The center of the spatial region of treatment was found in the anterior commissure - posterior commissure plane, 14.3 mm lateral from the midline, and 8.3 mm rostral to the posterior commissure. DATA CONCLUSION: In this pilot study a good correlation was found between the size of the lesion, the thermal dose, and the clinical outcome in patients treated for essential tremor with ablation of the VLpv with tcMRgFUS. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 4 J. Magn. Reson. Imaging 2017.
BACKGROUND: Transcranial MR-guided high-intensity focused ultrasound (tcMRgFUS) is a promising noninvasive method to treat medication-refractory essential tremor. PURPOSE/HYPOTHESIS: To define the correlation between lesion size after ablation, thermal dose, and clinical outcome in tcMRgFUS treatment of essential tremor. STUDY TYPE: Retrospective. POPULATION/SUBJECTS/PHANTOM/SPECIMEN/ANIMAL MODEL: Eight patients with medication-refractory essential tremor were treated using a tcMRgFUS system at 3T. FIELD STRENGTH/SEQUENCE: T2 -weighted images were acquired immediately and at 1 year posttreatment at 3T. ASSESSMENT: An atlas of the thalamic nuclei and dose maps were warped to the posttreatment images. The thermal dose, the immediate posttreatment lesion volume and 1-year final lesion volume, and the volumes confined inside the ventral division of the ventral lateral posterior thalamic nucleus (VLpv) were correlated to clinical outcome at 1 month and 1 year using Pearson's coefficient. The spatial region of treatment correlating with maximal clinical outcome was derived in a normalized space from average maps of clinical tremor score improvement at 1 year. STATISTICAL TESTS: Statistical significance was assessed using the Wilcoxon two-tailed rank test. RESULTS: The correlations between thermal dose, lesion volume posttreatment and at 1 year, and outcome at 1 year were good (r = 0.73, 0.65, 0.73, respectively), and were slightly better than at 1 month (r = 0.57, 0.49, 0.65). Reducing the measurement to include only the portion within the VLpv did not significantly modify the correlations (P = 0.09). The center of the spatial region of treatment was found in the anterior commissure - posterior commissure plane, 14.3 mm lateral from the midline, and 8.3 mm rostral to the posterior commissure. DATA CONCLUSION: In this pilot study a good correlation was found between the size of the lesion, the thermal dose, and the clinical outcome in patients treated for essential tremor with ablation of the VLpv with tcMRgFUS. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 4 J. Magn. Reson. Imaging 2017.
Authors: Ning Lu; Dinank Gupta; Badih J Daou; Adam Fox; Dave Choi; Jonathan R Sukovich; Timothy L Hall; Sandra Camelo-Piragua; Neeraj Chaudhary; John Snell; Aditya S Pandey; Douglas C Noll; Zhen Xu Journal: Ultrasound Med Biol Date: 2021-10-04 Impact factor: 3.694
Authors: William K Miller; Kathryn N Becker; Andrew J Caras; Tarek R Mansour; Malik T Mays; Mehmood Rashid; Jason Schwalb Journal: Neurosurg Rev Date: 2021-05-12 Impact factor: 3.042
Authors: Ning Lu; Timothy L Hall; Dave Choi; Dinank Gupta; Badih Junior Daou; Jonathan R Sukovich; Adam Fox; Tyler I Gerhardson; Aditya S Pandey; Douglas C Noll; Zhen Xu Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 2021-08-27 Impact factor: 3.267
Authors: Qiyuan Tian; Max Wintermark; W Jeffrey Elias; Pejman Ghanouni; Casey H Halpern; Jaimie M Henderson; Diane S Huss; Maged Goubran; Christian Thaler; Raag Airan; Michael Zeineh; Kim Butts Pauly; Jennifer A McNab Journal: Neuroimage Clin Date: 2018-05-09 Impact factor: 4.881
Authors: Mario Stanziano; Nico Golfrè Andreasi; Giuseppe Messina; Sara Rinaldo; Sara Palermo; Mattia Verri; Greta Demichelis; Jean Paul Medina; Francesco Ghielmetti; Salvatore Bonvegna; Anna Nigri; Giulia Frazzetta; Ludovico D'Incerti; Giovanni Tringali; Francesco DiMeco; Roberto Eleopra; Maria Grazia Bruzzone Journal: Front Neurol Date: 2022-01-12 Impact factor: 4.003
Authors: Myung Ji Kim; Kyung Won Chang; So Hee Park; Won Seok Chang; Hyun Ho Jung; Jin Woo Chang Journal: Front Neurol Date: 2021-06-09 Impact factor: 4.003
Authors: Jason H Su; Eun Young Choi; Thomas Tourdias; Manojkumar Saranathan; Casey H Halpern; Jaimie M Henderson; Kim Butts Pauly; Pejman Ghanouni; Brian K Rutt Journal: Hum Brain Mapp Date: 2020-08-06 Impact factor: 5.038